A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

NCT04925206 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Development plan change

Conditions

Transfusion Dependent Beta-Thalassaemia

Interventions

BIOLOGICAL: ET-01

Sponsor

EdiGene (GuangZhou) Inc.